175 related articles for article (PubMed ID: 35094296)
1. Anticancer Properties of Probiotic Saccharomyces boulardii Supernatant on Human Breast Cancer Cells.
Pakbin B; Dibazar SP; Allahyari S; Javadi M; Amani Z; Farasat A; Darzi S
Probiotics Antimicrob Proteins; 2022 Dec; 14(6):1130-1138. PubMed ID: 35094296
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Properties of Saccharomyces boulardii Metabolite Against Colon Cancer Cells.
Pakbin B; Allahyari S; Dibazar SP; Peymani A; Haghverdi MK; Taherkhani K; Javadi M; Mahmoudi R
Probiotics Antimicrob Proteins; 2024 Feb; 16(1):224-232. PubMed ID: 36547769
[TBL] [Abstract][Full Text] [Related]
3. Effects of Probiotic
Pakbin B; Allahyari S; Dibazar SP; Zolghadr L; Chermahini NK; Brück WM; Brück TB; Mahmoudi R
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175663
[TBL] [Abstract][Full Text] [Related]
4. Probiotic
Pakbin B; Pishkhan Dibazar S; Allahyari S; Javadi M; Farasat A; Darzi S
Food Sci Nutr; 2021 Feb; 9(2):692-700. PubMed ID: 33598154
[TBL] [Abstract][Full Text] [Related]
5. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.
Jin Y; Yu S; Liu JJ; Yun EJ; Lee JW; Jin YS; Kim KH
Microb Cell Fact; 2021 Aug; 20(1):160. PubMed ID: 34407819
[TBL] [Abstract][Full Text] [Related]
6. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
[TBL] [Abstract][Full Text] [Related]
7. Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces boulardii.
Fu J; Liu J; Wen X; Zhang G; Cai J; Qiao Z; An Z; Zheng J; Li L
Probiotics Antimicrob Proteins; 2023 Aug; 15(4):967-982. PubMed ID: 35608794
[TBL] [Abstract][Full Text] [Related]
8. A Mutation in
Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
[TBL] [Abstract][Full Text] [Related]
9. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
Sen S; Mansell TJ
Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
[TBL] [Abstract][Full Text] [Related]
10. New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii.
Samakkarn W; Vandecruys P; Moreno MRF; Thevelein J; Ratanakhanokchai K; Soontorngun N
Appl Microbiol Biotechnol; 2024 Jan; 108(1):153. PubMed ID: 38240846
[TBL] [Abstract][Full Text] [Related]
11. Application of Saccharomyces cerevisiae var. boulardii in food processing: a review.
Lazo-Vélez MA; Serna-Saldívar SO; Rosales-Medina MF; Tinoco-Alvear M; Briones-García M
J Appl Microbiol; 2018 Oct; 125(4):943-951. PubMed ID: 29961970
[TBL] [Abstract][Full Text] [Related]
12. Health-promoting properties of
Ansari F; Alian Samakkhah S; Bahadori A; Jafari SM; Ziaee M; Khodayari MT; Pourjafar H
Crit Rev Food Sci Nutr; 2023; 63(4):457-485. PubMed ID: 34254862
[No Abstract] [Full Text] [Related]
13. Microbiome Engineering Using Probiotic Yeast:
Kim J; Atkinson C; Miller MJ; Kim KH; Jin YS
Microbiol Spectr; 2023 Aug; 11(4):e0078023. PubMed ID: 37436157
[TBL] [Abstract][Full Text] [Related]
14. Antigenotoxicity and Cytotoxic Potentials of Cell-Free Supernatants Derived from Saccharomyces cerevisiae var. boulardii on HT-29 Human Colon Cancer Cell Lines.
Abbasi A; Rad AH; Maleki LA; Kafil HS; Baghbanzadeh A
Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1583-1595. PubMed ID: 36588138
[TBL] [Abstract][Full Text] [Related]
15. Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota.
Gu Y; Wang C; Qin X; Zhou B; Liu X; Liu T; Xie R; Liu J; Wang B; Cao H
Pharmacol Res; 2022 Jul; 181():106291. PubMed ID: 35690329
[TBL] [Abstract][Full Text] [Related]
16. Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews.
Chan MZA; Toh M; Liu SQ
Int J Food Microbiol; 2021 Jul; 350():109229. PubMed ID: 34023682
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic.
Wombwell E; Bransteitter B; Gillen LR
Mycoses; 2021 Dec; 64(12):1521-1526. PubMed ID: 34585799
[TBL] [Abstract][Full Text] [Related]
18. Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.
Douradinha B; Reis VC; Rogers MB; Torres FA; Evans JD; Marques ET
Bioengineered; 2014; 5(1):21-9. PubMed ID: 24013355
[TBL] [Abstract][Full Text] [Related]
19. Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing L-fucose, a mammalian mucin component.
Kim J; Cheong YE; Yu S; Jin YS; Kim KH
Microb Cell Fact; 2022 Oct; 21(1):204. PubMed ID: 36207743
[TBL] [Abstract][Full Text] [Related]
20.
Durmusoglu D; Al'Abri IS; Collins SP; Cheng J; Eroglu A; Beisel CL; Crook N
ACS Synth Biol; 2021 May; 10(5):1039-1052. PubMed ID: 33843197
[No Abstract] [Full Text] [Related]
[Next] [New Search]
